Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
John Hancock Tax Advantaged Dividend Fund	HTD	26. nov 2024	23.44	+0.09
John Marshall Bancorp	JMSB	26. nov 2024	23.19	-2.81
John Wiley & Sons A	WLY	26. nov 2024	53.11	-0.04
John Wiley & Sons B	WLYB	26. nov 2024	52.90	0.00
Johnson & Johnson	JNJ	26. nov 2024	154.52	-0.81
Johnson Controls International	JCI	26. nov 2024	83.75	+0.49
Johnson Outdoors A	JOUT	26. nov 2024	32.80	-4.29
Joint Stock Company Kaspi.kz	KSPI	26. nov 2024	109.62	+3.23
Jones Lang LaSalle	JLL	26. nov 2024	283.23	-0.16
Journey Medical	DERM	26. nov 2024	5.55	-3.31
Jowell Global	JWEL	26. nov 2024	3.39	-0.88
JOYY ADR	YY	26. nov 2024	35.00	+0.72
JP Morgan Chase	JPM	26. nov 2024	249.97	-0.13
JP Morgan Chase & Co EE Pref	JPM-C	26. nov 2024	25.36	-0.51
JP Morgan Chase & Co GG Pref	JPM-J	26. nov 2024	22.13	-1.12
JP Morgan Chase & Co Ser DD Pref	JPM-D	26. nov 2024	25.10	-0.75
JPMorgan Nasdaq Equity Premium Income ETF	JEPQ	26. nov 2024	56.97	+0.49
Jumia Technologies ADR	JMIA	26. nov 2024	3.96	-3.65
Junee Limited - Ordinary Shares	JUNE	26. nov 2024	4.68	-1.68
Junior Gold Miners ETF Market Vectors	GDXJ	26. nov 2024	46.67	-0.32
Juniper Networks	JNPR	26. nov 2024	36.02	-0.50
JVSPAC Acquisition	JVSAU	26. nov 2024	10.90	0.00
JVSPAC Acquisition	JVSA	26. nov 2024	10.39	0.00
JX Luxventure	JXJT	26. nov 2024	1.30	+6.56
Kadant	KAI	26. nov 2024	422.93	+1.02
Kairos Pharma	KAPA	26. nov 2024	1.70	0.00
Kairous Acquisition	KACL	26. nov 2024	12.46	-0.32
Kaiser Aluminium	KALU	26. nov 2024	81.68	-2.51
Kaival Brands Innovations Group	KAVL	26. nov 2024	0.73	+1.22
Kaixin Holdings	KXIN	26. nov 2024	1.96	-1.51

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.